![](https://www.benefitscanada.com/wp-content/uploads/sites/7/2024/06/weight-loss1.jpg)
34% of U.S. employers covering GLP-1s for both diabetes, weight loss: survey
Roughly a third (34 per cent) of employers in the U.S. are providing coverage for glucagon-like peptide-1 medications for both diabetes care and weight-loss management in 2024, up…
- By: Staff
- June 24, 2024 June 21, 2024
- 09:00